Taiwan's emerging stock TCI Gene Inc. announced on the 18th that it has reached a strategic cooperation with Alpro Pharmacy, the leading chain pharmacy in Malaysia. TCI Gene has granted exclusive agency rights to Alpro Pharmacy for its genetic testing products and will sell them through Alpro Pharmacy outlets in Malaysia. This service has been officially launched in the Malaysian market since April, providing consumers with higher quality and more precise preventive medical services.
TCI Gene stated that Alpro Pharmacy is the largest chain pharmacy in Malaysia, with over 300 chain outlets, as well as clinics and physiotherapy centers. This agreement signed between TCI Gene and Alpro Pharmacy marks an important milestone in entering the Southeast Asian market. With a population of 33.4 million as of 2023, Malaysia serves as the first stop for TCI Gene to promote its international genetic testing services.
After cooperating with Alpro Pharmacy, relevant information about genetic testing services will be available in pharmacies, clinics, and rehabilitation centers in Malaysia. The distribution channels will guide consumers to the mydna360 official website in Malaysia, where consumers can obtain test kits and perform self-sampling at home.
Grace Fu, General Manager of TCI Gene, expressed that the collaboration with Alpro Pharmacy represents a powerful alliance to seize the Malaysian market in preventive medicine and personalized health management. In addition to enhancing the international visibility of precision medicine in Taiwan and facilitating bilateral and multilateral international exchanges, there is also an opportunity to open up new possibilities for global preventive medicine channels, contributing to human health and driving the operational momentum of TCI Gene.
TCI Gene' "genetic testing" is currently promoted in domestic medical institutions, focusing on genetic detection points with the highest global disease risks. It combines genetic medicine and systems biology for comprehensive AI big data computation and incorporates global genetic databases, covering 10 major health systems, 58 health risks, and genetic testing for high-risk genes.
In addition to predicting the health risks faced by individuals and providing preventive recommendations, TCI Gene also realizes personalized precision prevention, tailoring exclusive health strategies to individuals, aiming to bring a healthier life to the public and stay ahead of time.
Resource (Mandarin):
